These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacokinetics of a single dose of teicoplanin in burn patients. Steer JA, Papini RP, Wilson AP, Dhillon S, Hichens MF, McGrouther DA, Frame JD, Parkhouse N. J Antimicrob Chemother; 1996 Mar; 37(3):545-53. PubMed ID: 9182111 [Abstract] [Full Text] [Related]
6. Age- and gender-related differences in teicoplanin levels in paediatric patients. Strenger V, Hofer N, Rödl S, Hönigl M, Raggam R, Seidel MG, Dornbusch HJ, Sperl D, Lackner H, Schwinger W, Sovinz P, Benesch M, Urlesberger B, Urban C. J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837 [Abstract] [Full Text] [Related]
7. Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration. Bellmann R, Falkensammer G, Seger C, Weiler S, Kountchev J, Joannidis M. Int J Clin Pharmacol Ther; 2010 Apr; 48(4):243-9. PubMed ID: 20353745 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors. Barbot A, Venisse N, Rayeh F, Bouquet S, Debaene B, Mimoz O. Intensive Care Med; 2003 Sep; 29(9):1528-34. PubMed ID: 12856119 [Abstract] [Full Text] [Related]
13. Influence of arterio-venous haemofiltration on teicoplanin elimination. Hillaire-Buys D, Peyriere H, Lobjoie E, Bres J, Ossart M, Despaux E. Br J Clin Pharmacol; 1995 Jul; 40(1):95-7. PubMed ID: 8527277 [Abstract] [Full Text] [Related]